Go to DAY 1 DAY 2 BACK to EHDN2022
| PLENARY SESSION IV: Advanced Therapies for HD Chaired by Anne Rosser and Romina Aron-Badin |
||
|
Introduction – Overview of Challenges in Delivering Advanced Therapies to the Brain in HD Romina Aron-Badin |
How Do We Innovate? Challenges of Delivering Substances to the Brain and Trial Design Liam Gray |
How Do We Innovate? Challenges of Delivering Substances to the Brain and Trial Design Cheney Drew |
| No Video
What is New? Cell Therapy |
What is New? Deep Brain Stimulation (DBS) Jan Vesper |
Discussion All |
| PLENARY SESSION V: Update on Planned Clinical Trials; Chaired by Tim McLean and Bernhard Landwehrmeyer |
|||
|
AskBio Nathalie Cartier-Lacave |
Sage Therapeutics Aaron Koenig |
||
Roche Peter McColgan |
Annexon Henk-André Kroon |
||
| ROUND-UP, POSTER AWARDS AND FAREWELL |
Patrick Weydt, Åsa Petersén and Anne Rosser |